ZEISS has launched the Axioscan 7 spatial biology, a high-performance slide scanner designed for clinical research applications in spatial biolog ...

Enjoy the ‘small town feel’ in one of the fastest-growing cities in the country during this weekend’s Georgetown Poppy ...

Uncertainty surrounding President Trump’s import tariffs have been “cataclysmic” for the U.S. biotech industry, but the dust ...

Speculators take on risk, especially when anticipating future price movements, hoping to make large gains to offset the risk.

Six posters highlight continued progress across antibody-drug conjugate and T cell engager platforms Novel T cell engager ZW209 demonstrates durable activity in small cell lung cancer; IND submission ...

IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines, today announced the presentation of new ...

Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional ...

Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel class of biologic therapy to treat solid tumor cancers and chemotherapy-induced peripheral neuropathy (CIPN) ...

AF Gruppen has been selected by Lunds Kommun Fastighets AB (LKF) to build 117 new rental apartments in Lund's Råbykungen district, with a contra ...

Conference/Scientific publicationPentixapharm to Present First-in-Class Glycan-Dependent CD24 Antibody GT-008 for Solid Tumors at AACR 2025 25.04.2025 / 15:39 CET/CESTThe issuer is solely responsible ...

The Institute of Biotechnology and Genetic Engineering (IBGE) at Gazipur Agricultural University (GAU) celebrated World DNA ...